Project: A Gene Therapy for Resynchronization of Cardiac Conduction in Pacing-Induced Cardiomyopathy.
| Acronym | SYNCHROPACE (Reference Number: 115484) |
| Duration | 01/11/2021 - 01/11/2024 |
| Project Topic | A first-ever cardiac Gene Therapy Medicinal Product (GTMP) mediated by adeno-associated virus (AAV) to treat pacing-induced cardiomyopathy (PICM). Our technique involves a proprietary technology to restore ion channels in the heart to generate and resynchronize cardiac pacing function. A GTMP’s safety and efficacy package in line with authorities will allow the compilation and submission of a CTA / IND within 9 months after the project will be concluded. |
| Network | Eurostars 2 |
| Call | Eurostars Cut–off 15 |
Project partner
| Number | Name | Role | Country |
|---|---|---|---|
| 1 | PacingCure B.V. | Coordinator | Netherlands |
| 2 | Academisch Medisch Centrum, part of Amsterdam UMC | Partner | Netherlands |
| 3 | Naason Science Inc. | Partner | Korea, Republic of |
| 4 | PharmaPrice International Ltd. | Partner | United Kingdom |
| 5 | SIRION Biotech GmbH | Partner | Germany |